Table 3.
Tamoxifen exposure in the BC first group.
| Endometrioid | Serous | total | |
|---|---|---|---|
| Tamoxifen. n (%) | 12 (63.1%) | 9 (52.9%) | 21 |
| No tamoxifen, n (%) | 7 (36.9%) | 8 (47.1%) | 15 |
| Total, n | 19 | 17 | 36 |
n: Number.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.